Selected research
Market Structure
Global Plant Sources Anti Cancer Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Plant Sources Anti Cancer Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Plant Sources Anti Cancer Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Plant Sources Anti Cancer Agents include Yunnan Hande, Pfizer, Hainan Yew Pharm, West-Ward Pharmaceuticals, TAPI (Teva), Taj Pharma, Southpharma, ScinoPharm and Samyang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Plant Sources Anti Cancer Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Plant Sources Anti Cancer Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Plant Sources Anti Cancer Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Plant Sources Anti Cancer Agents market size, projected growth trends, production technologies, key applications, and end-use industries.
Plant Sources Anti Cancer Agents Segment by Company
Yunnan Hande
Pfizer
Hainan Yew Pharm
West-Ward Pharmaceuticals
TAPI (Teva)
Taj Pharma
Southpharma
ScinoPharm
Samyang
Salius
Polymed
Phyton
Novasep
Jiangsu Yew Biotechnology
Huiang biopharma
Getwell
Fresenius-kabi
Cipla
Actiza Pharmaceutical
Plant Sources Anti Cancer Agents Segment by Type
Paclitaxel
Vinorelbine
Irinotecan
Hydroxycamptothecin
Docetaxel
Other
Plant Sources Anti Cancer Agents Segment by Application
Breast Cancer
Ovarian Cancer
Cervical Cancer
Other
Plant Sources Anti Cancer Agents Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant Sources Anti Cancer Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant Sources Anti Cancer Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant Sources Anti Cancer Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Plant Sources Anti Cancer Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plant Sources Anti Cancer Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plant Sources Anti Cancer Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Plant Sources Anti Cancer Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Plant Sources Anti Cancer Agents Industry Trends
Table 2. Plant Sources Anti Cancer Agents Industry Drivers
Table 3. Plant Sources Anti Cancer Agents Industry Opportunities and Challenges
Table 4. Plant Sources Anti Cancer Agents Industry Restraints
Table 5. Global Plant Sources Anti Cancer Agents Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Plant Sources Anti Cancer Agents Sales by Manufacturers (tons) & (2021-2026)
Table 8. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers
Table 9. Global Plant Sources Anti Cancer Agents Average Sales Price (US$/kg) of Manufacturers (2021-2026)
Table 10. Global Plant Sources Anti Cancer Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Plant Sources Anti Cancer Agents Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Plant Sources Anti Cancer Agents Manufacturers, Product Type & Application
Table 13. Global Plant Sources Anti Cancer Agents Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Plant Sources Anti Cancer Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Paclitaxel
Table 17. Major Manufacturers of Vinorelbine
Table 18. Major Manufacturers of Irinotecan
Table 19. Major Manufacturers of Hydroxycamptothecin
Table 20. Major Manufacturers of Docetaxel
Table 21. Major Manufacturers of Other
Table 22. Global Plant Sources Anti Cancer Agents Sales by Type 2021 VS 2025 VS 2032 (tons)
Table 23. Global Plant Sources Anti Cancer Agents Sales by Type (2021-2026) & (tons)
Table 24. Global Plant Sources Anti Cancer Agents Sales by Type (2027-2032) & (tons)
Table 25. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2026)
Table 26. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2027-2032)
Table 27. Global Plant Sources Anti Cancer Agents Revenue by Type 2021 VS 2025 VS 2032 (tons)
Table 28. Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2026) & (tons)
Table 29. Global Plant Sources Anti Cancer Agents Revenue by Type (2027-2032) & (tons)
Table 30. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2026)
Table 31. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2027-2032)
Table 32. Major Manufacturers of Breast Cancer
Table 33. Major Manufacturers of Ovarian Cancer
Table 34. Major Manufacturers of Cervical Cancer
Table 35. Major Manufacturers of Other
Table 36. Global Plant Sources Anti Cancer Agents Sales by Application 2021 VS 2025 VS 2032 (tons)
Table 37. Global Plant Sources Anti Cancer Agents Sales by Application (2021-2026) & (tons)
Table 38. Global Plant Sources Anti Cancer Agents Sales by Application (2027-2032) & (tons)
Table 39. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2026)
Table 40. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2027-2032)
Table 41. Global Plant Sources Anti Cancer Agents Revenue by Application 2021 VS 2025 VS 2032 (tons)
Table 42. Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2026) & (tons)
Table 43. Global Plant Sources Anti Cancer Agents Revenue by Application (2027-2032) & (tons)
Table 44. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2026)
Table 45. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2027-2032)
Table 46. Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032 (tons)
Table 47. Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026) & (tons)
Table 48. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2021-2026)
Table 49. Global Plant Sources Anti Cancer Agents Sales Forecasted by Region (2027-2032) & (tons)
Table 50. Global Plant Sources Anti Cancer Agents Sales Forecasted Market Share by Region (2027-2032)
Table 51. North America Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons)
Table 52. North America Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 53. North America Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 54. Europe Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons)
Table 55. Europe Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 56. Europe Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 57. Asia Pacific Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons)
Table 58. Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 59. Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 60. South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons)
Table 61. South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2021-2026) & (tons)
Table 62. South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2027-2032) & (tons)
Table 63. Global Plant Sources Anti Cancer Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 64. Global Plant Sources Anti Cancer Agents Revenue by Region (2021-2026) & (US$ Million)
Table 65. Global Plant Sources Anti Cancer Agents Revenue by Region (2027-2032) & (US$ Million)
Table 66. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2021-2026)
Table 67. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2027-2032)
Table 68. Yunnan Hande Company Information
Table 69. Yunnan Hande Business Overview
Table 70. Yunnan Hande Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
Table 72. Yunnan Hande Recent Development
Table 73. Pfizer Company Information
Table 74. Pfizer Business Overview
Table 75. Pfizer Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 76. Pfizer Plant Sources Anti Cancer Agents Product Portfolio
Table 77. Pfizer Recent Development
Table 78. Hainan Yew Pharm Company Information
Table 79. Hainan Yew Pharm Business Overview
Table 80. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 81. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
Table 82. Hainan Yew Pharm Recent Development
Table 83. West-Ward Pharmaceuticals Company Information
Table 84. West-Ward Pharmaceuticals Business Overview
Table 85. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 86. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
Table 87. West-Ward Pharmaceuticals Recent Development
Table 88. TAPI (Teva) Company Information
Table 89. TAPI (Teva) Business Overview
Table 90. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 91. TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
Table 92. TAPI (Teva) Recent Development
Table 93. Taj Pharma Company Information
Table 94. Taj Pharma Business Overview
Table 95. Taj Pharma Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 96. Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
Table 97. Taj Pharma Recent Development
Table 98. Southpharma Company Information
Table 99. Southpharma Business Overview
Table 100. Southpharma Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 101. Southpharma Plant Sources Anti Cancer Agents Product Portfolio
Table 102. Southpharma Recent Development
Table 103. ScinoPharm Company Information
Table 104. ScinoPharm Business Overview
Table 105. ScinoPharm Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 106. ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
Table 107. ScinoPharm Recent Development
Table 108. Samyang Company Information
Table 109. Samyang Business Overview
Table 110. Samyang Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 111. Samyang Plant Sources Anti Cancer Agents Product Portfolio
Table 112. Samyang Recent Development
Table 113. Salius Company Information
Table 114. Salius Business Overview
Table 115. Salius Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 116. Salius Plant Sources Anti Cancer Agents Product Portfolio
Table 117. Salius Recent Development
Table 118. Polymed Company Information
Table 119. Polymed Business Overview
Table 120. Polymed Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 121. Polymed Plant Sources Anti Cancer Agents Product Portfolio
Table 122. Polymed Recent Development
Table 123. Phyton Company Information
Table 124. Phyton Business Overview
Table 125. Phyton Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 126. Phyton Plant Sources Anti Cancer Agents Product Portfolio
Table 127. Phyton Recent Development
Table 128. Novasep Company Information
Table 129. Novasep Business Overview
Table 130. Novasep Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 131. Novasep Plant Sources Anti Cancer Agents Product Portfolio
Table 132. Novasep Recent Development
Table 133. Jiangsu Yew Biotechnology Company Information
Table 134. Jiangsu Yew Biotechnology Business Overview
Table 135. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 136. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
Table 137. Jiangsu Yew Biotechnology Recent Development
Table 138. Huiang biopharma Company Information
Table 139. Huiang biopharma Business Overview
Table 140. Huiang biopharma Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 141. Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
Table 142. Huiang biopharma Recent Development
Table 143. Getwell Company Information
Table 144. Getwell Business Overview
Table 145. Getwell Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 146. Getwell Plant Sources Anti Cancer Agents Product Portfolio
Table 147. Getwell Recent Development
Table 148. Fresenius-kabi Company Information
Table 149. Fresenius-kabi Business Overview
Table 150. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 151. Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
Table 152. Fresenius-kabi Recent Development
Table 153. Cipla Company Information
Table 154. Cipla Business Overview
Table 155. Cipla Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 156. Cipla Plant Sources Anti Cancer Agents Product Portfolio
Table 157. Cipla Recent Development
Table 158. Actiza Pharmaceutical Company Information
Table 159. Actiza Pharmaceutical Business Overview
Table 160. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 161. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
Table 162. Actiza Pharmaceutical Recent Development
Table 163. Key Raw Materials
Table 164. Raw Materials Key Suppliers
Table 165. Plant Sources Anti Cancer Agents Distributors List
Table 166. Plant Sources Anti Cancer Agents Customers List
Table 167. Research Programs/Design for This Report
Table 168. Authors List of This Report
Table 169. Secondary Sources
Table 170. Primary Sources
List of Figures
Figure 1. Plant Sources Anti Cancer Agents Product Image
Figure 2. Global Plant Sources Anti Cancer Agents Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Plant Sources Anti Cancer Agents Market Size (2021-2032) & (US$ Million)
Figure 4. Global Plant Sources Anti Cancer Agents Sales (2021-2032) & (tons)
Figure 5. Global Plant Sources Anti Cancer Agents Average Price (US$/kg) & (2021-2032)
Figure 6. Global Top 5 and 10 Plant Sources Anti Cancer Agents Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Paclitaxel Image
Figure 9. Vinorelbine Image
Figure 10. Irinotecan Image
Figure 11. Hydroxycamptothecin Image
Figure 12. Docetaxel Image
Figure 13. Other Image
Figure 14. Global Plant Sources Anti Cancer Agents Sales by Type (2021 VS 2025 VS 2032) & (tons)
Figure 15. Global Plant Sources Anti Cancer Agents Sales Market Share 2021 VS 2025 VS 2032
Figure 16. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2032)
Figure 17. Global Plant Sources Anti Cancer Agents Revenue by Type (2021 VS 2025 VS 2032) & (tons)
Figure 18. Global Plant Sources Anti Cancer Agents Revenue Market Share 2021 VS 2025 VS 2032
Figure 19. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2032)
Figure 20. Breast Cancer Image
Figure 21. Ovarian Cancer Image
Figure 22. Cervical Cancer Image
Figure 23. Other Image
Figure 24. Global Plant Sources Anti Cancer Agents Sales by Application (2021 VS 2025 VS 2032) & (tons)
Figure 25. Global Plant Sources Anti Cancer Agents Sales Market Share 2021 VS 2025 VS 2032
Figure 26. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2032)
Figure 27. Global Plant Sources Anti Cancer Agents Revenue by Application (2021 VS 2025 VS 2032) & (tons)
Figure 28. Global Plant Sources Anti Cancer Agents Revenue Market Share 2021 VS 2025 VS 2032
Figure 29. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2032)
Figure 30. North America Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 31. North America Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 32. U.S. Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 33. Canada Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 34. Mexico Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 35. Europe Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 36. Europe Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 37. Germany Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 38. France Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 39. U.K. Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 40. Italy Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 41. Netherlands Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 42. Asia Pacific Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 43. Asia Pacific Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 44. China Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 45. Japan Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 46. South Korea Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 47. Southeast Asia Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 48. India Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 49. Australia Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 50. South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 51. South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales Market Share by Country (2021-2032)
Figure 52. Brazil Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 53. South Africa Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 54. Saudi Arabia Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 55. Turkey Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 56. Argentina Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 57. UAE Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 58. Egypt Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 59. Chile Plant Sources Anti Cancer Agents Sales and Growth Rate (2021-2032) & (tons)
Figure 60. Global Plant Sources Anti Cancer Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 61. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 62. North America Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million)
Figure 63. North America Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 64. Europe Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million)
Figure 65. Europe Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 66. Asia-Pacific Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million)
Figure 67. Asia-Pacific Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 68. South America, Middle East and Africa Plant Sources Anti Cancer Agents Revenue (2021-2032) & (US$ Million)
Figure 69. South America, Middle East and Africa Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 70. Plant Sources Anti Cancer Agents Value Chain
Figure 71. Manufacturing Cost Structure
Figure 72. Plant Sources Anti Cancer Agents Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Years Considered
Figure 76. Research Process
Figure 77. Key Executives Interviewed
Scope & coverage.
Types
- Paclitaxel
- Vinorelbine
- Irinotecan
- Hydroxycamptothecin
- Docetaxel
- Other
Applications
- Breast Cancer
- Ovarian Cancer
- Cervical Cancer
- Other
Companies covered
- Yunnan Hande
- Pfizer
- Hainan Yew Pharm
- West-Ward Pharmaceuticals
- TAPI (Teva)
- Taj Pharma
- Southpharma
- ScinoPharm
- Samyang
- Salius
- Polymed
- Phyton
- Novasep
- Jiangsu Yew Biotechnology
- Huiang biopharma
- Getwell
- Fresenius-kabi
- Cipla
- Actiza Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Plant Sources Anti Cancer Agents Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Plant Sources Anti Cancer Agents Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Plant Sources Anti Cancer Agents Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Plant Sources Anti Cancer Agents Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Plant Sources Anti Cancer Agents Market Dynamics
- 2.1 Plant Sources Anti Cancer Agents Industry Trends
- 2.2 Plant Sources Anti Cancer Agents Industry Drivers
- 2.3 Plant Sources Anti Cancer Agents Industry Opportunities and Challenges
- 2.4 Plant Sources Anti Cancer Agents Industry Restraints
3 Plant Sources Anti Cancer Agents Market by Manufacturers
- 3.1 Global Plant Sources Anti Cancer Agents Revenue by Manufacturers (2021-2026)
- 3.2 Global Plant Sources Anti Cancer Agents Sales by Manufacturers (2021-2026)
- 3.3 Global Plant Sources Anti Cancer Agents Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Plant Sources Anti Cancer Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Plant Sources Anti Cancer Agents Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Plant Sources Anti Cancer Agents Manufacturers, Product Type & Application
- 3.7 Global Plant Sources Anti Cancer Agents Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Plant Sources Anti Cancer Agents Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Plant Sources Anti Cancer Agents Players Market Share by Revenue in 2025
- 3.8.3 2025 Plant Sources Anti Cancer Agents Tier 1, Tier 2, and Tier 3
4 Plant Sources Anti Cancer Agents Market by Type
- 4.1 Plant Sources Anti Cancer Agents Type Introduction
- 4.1.1 Paclitaxel
- 4.1.2 Vinorelbine
- 4.1.3 Irinotecan
- 4.1.4 Hydroxycamptothecin
- 4.1.5 Docetaxel
- 4.1.6 Other
- 4.2 Global Plant Sources Anti Cancer Agents Sales by Type
- 4.2.1 Global Plant Sources Anti Cancer Agents Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Plant Sources Anti Cancer Agents Sales by Type (2021-2032)
- 4.2.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2021-2032)
- 4.3 Global Plant Sources Anti Cancer Agents Revenue by Type
- 4.3.1 Global Plant Sources Anti Cancer Agents Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2021-2032)
- 4.3.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2021-2032)
5 Plant Sources Anti Cancer Agents Market by Application
- 5.1 Plant Sources Anti Cancer Agents Application Introduction
- 5.1.1 Breast Cancer
- 5.1.2 Ovarian Cancer
- 5.1.3 Cervical Cancer
- 5.1.4 Other
- 5.2 Global Plant Sources Anti Cancer Agents Sales by Application
- 5.2.1 Global Plant Sources Anti Cancer Agents Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Plant Sources Anti Cancer Agents Sales by Application (2021-2032)
- 5.2.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2021-2032)
- 5.3 Global Plant Sources Anti Cancer Agents Revenue by Application
- 5.3.1 Global Plant Sources Anti Cancer Agents Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2021-2032)
- 5.3.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2021-2032)
6 Global Plant Sources Anti Cancer Agents Sales by Region
- 6.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Plant Sources Anti Cancer Agents Sales by Region (2021-2032)
- 6.2.1 Global Plant Sources Anti Cancer Agents Sales by Region (2021-2026)
- 6.2.2 Global Plant Sources Anti Cancer Agents Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Plant Sources Anti Cancer Agents Revenue by Region
- 7.1 Global Plant Sources Anti Cancer Agents Revenue by Region
- 7.1.1 Global Plant Sources Anti Cancer Agents Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Plant Sources Anti Cancer Agents Revenue by Region (2021-2026)
- 7.1.3 Global Plant Sources Anti Cancer Agents Revenue by Region (2027-2032)
- 7.1.4 Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Plant Sources Anti Cancer Agents Revenue (2021-2032)
- 7.2.2 North America Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Plant Sources Anti Cancer Agents Revenue (2021-2032)
- 7.3.2 Europe Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Plant Sources Anti Cancer Agents Revenue (2021-2032)
- 7.4.2 Asia-Pacific Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Plant Sources Anti Cancer Agents Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Plant Sources Anti Cancer Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Yunnan Hande
- 8.1.1 Yunnan Hande Company Information
- 8.1.2 Yunnan Hande Business Overview
- 8.1.3 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio
- 8.1.5 Yunnan Hande Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Plant Sources Anti Cancer Agents Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Hainan Yew Pharm
- 8.3.1 Hainan Yew Pharm Company Information
- 8.3.2 Hainan Yew Pharm Business Overview
- 8.3.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio
- 8.3.5 Hainan Yew Pharm Recent Developments
- 8.4 West-Ward Pharmaceuticals
- 8.4.1 West-Ward Pharmaceuticals Company Information
- 8.4.2 West-Ward Pharmaceuticals Business Overview
- 8.4.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio
- 8.4.5 West-Ward Pharmaceuticals Recent Developments
- 8.5 TAPI (Teva)
- 8.5.1 TAPI (Teva) Company Information
- 8.5.2 TAPI (Teva) Business Overview
- 8.5.3 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio
- 8.5.5 TAPI (Teva) Recent Developments
- 8.6 Taj Pharma
- 8.6.1 Taj Pharma Company Information
- 8.6.2 Taj Pharma Business Overview
- 8.6.3 Taj Pharma Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio
- 8.6.5 Taj Pharma Recent Developments
- 8.7 Southpharma
- 8.7.1 Southpharma Company Information
- 8.7.2 Southpharma Business Overview
- 8.7.3 Southpharma Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Southpharma Plant Sources Anti Cancer Agents Product Portfolio
- 8.7.5 Southpharma Recent Developments
- 8.8 ScinoPharm
- 8.8.1 ScinoPharm Company Information
- 8.8.2 ScinoPharm Business Overview
- 8.8.3 ScinoPharm Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio
- 8.8.5 ScinoPharm Recent Developments
- 8.9 Samyang
- 8.9.1 Samyang Company Information
- 8.9.2 Samyang Business Overview
- 8.9.3 Samyang Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Samyang Plant Sources Anti Cancer Agents Product Portfolio
- 8.9.5 Samyang Recent Developments
- 8.10 Salius
- 8.10.1 Salius Company Information
- 8.10.2 Salius Business Overview
- 8.10.3 Salius Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Salius Plant Sources Anti Cancer Agents Product Portfolio
- 8.10.5 Salius Recent Developments
- 8.11 Polymed
- 8.11.1 Polymed Company Information
- 8.11.2 Polymed Business Overview
- 8.11.3 Polymed Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Polymed Plant Sources Anti Cancer Agents Product Portfolio
- 8.11.5 Polymed Recent Developments
- 8.12 Phyton
- 8.12.1 Phyton Company Information
- 8.12.2 Phyton Business Overview
- 8.12.3 Phyton Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Phyton Plant Sources Anti Cancer Agents Product Portfolio
- 8.12.5 Phyton Recent Developments
- 8.13 Novasep
- 8.13.1 Novasep Company Information
- 8.13.2 Novasep Business Overview
- 8.13.3 Novasep Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Novasep Plant Sources Anti Cancer Agents Product Portfolio
- 8.13.5 Novasep Recent Developments
- 8.14 Jiangsu Yew Biotechnology
- 8.14.1 Jiangsu Yew Biotechnology Company Information
- 8.14.2 Jiangsu Yew Biotechnology Business Overview
- 8.14.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio
- 8.14.5 Jiangsu Yew Biotechnology Recent Developments
- 8.15 Huiang biopharma
- 8.15.1 Huiang biopharma Company Information
- 8.15.2 Huiang biopharma Business Overview
- 8.15.3 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio
- 8.15.5 Huiang biopharma Recent Developments
- 8.16 Getwell
- 8.16.1 Getwell Company Information
- 8.16.2 Getwell Business Overview
- 8.16.3 Getwell Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Getwell Plant Sources Anti Cancer Agents Product Portfolio
- 8.16.5 Getwell Recent Developments
- 8.17 Fresenius-kabi
- 8.17.1 Fresenius-kabi Company Information
- 8.17.2 Fresenius-kabi Business Overview
- 8.17.3 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio
- 8.17.5 Fresenius-kabi Recent Developments
- 8.18 Cipla
- 8.18.1 Cipla Company Information
- 8.18.2 Cipla Business Overview
- 8.18.3 Cipla Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Cipla Plant Sources Anti Cancer Agents Product Portfolio
- 8.18.5 Cipla Recent Developments
- 8.19 Actiza Pharmaceutical
- 8.19.1 Actiza Pharmaceutical Company Information
- 8.19.2 Actiza Pharmaceutical Business Overview
- 8.19.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio
- 8.19.5 Actiza Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Plant Sources Anti Cancer Agents Value Chain Analysis
- 9.1.1 Plant Sources Anti Cancer Agents Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Plant Sources Anti Cancer Agents Production Mode & Process
- 9.2 Plant Sources Anti Cancer Agents Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Plant Sources Anti Cancer Agents Distributors
- 9.2.3 Plant Sources Anti Cancer Agents Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst